Investegate |Redx Pharma plc Announcements | Redx Pharma plc: Encouraging Data on Porcupine and ROCK Inhibitors
Investegate announcements from Redx Pharma plc, Encouraging Data on Porcupine and ROCK Inhibitors
Source: investegate.co.uk
Stay updated with breaking news from Strategic Program Lead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Redx Pharma plc, Encouraging Data on Porcupine and ROCK Inhibitors
Clinical-stage biotechnology company Redx and the Garvan Institute of Medical Research (Australia) are jointly researching possible treatments for increased patient survival in poorly treated, highly fibrotic cancers, such as pancreatic cancer. Click to read more...